Starting from the 1970s, the world clinical practice switched the transfusion and infusion therapy priorities from the use of donor blood towards the use of blood substitute solutions. This circumstance is determined by a number of factors: the high therapeutic effectiveness of products, the lack of need to select drugs by group antigens and rhesus factor, good tolerance, almost no allergenic properties, low cost of products and, most importantly, the exception of the infectious diseases transmission risk (viral hepatitis, infectious mononucleosis, syphilis, AIDS, etc.).
In a healthy person the quantitative composition of blood varies slightly with age but it is significantly changed by various diseases. The violation of balance between the qualitative and quantitative composition of inorganic salts of intracellular and extracellular fluids takes place, i.e. the violation of water-electrolytic balance.
Infusions of various solutions solve a wide range of tasks from the introduction of medicinal substances to life support. Different treatments in the areas of resuscitation, surgery, obstetrics, gynecology, infectious diseases and therapy include infusion of various fluids and substances. Hardly an area of medicine exists where infusion therapy is not used.
The plant is able to produce infusion solutions in different types of package, including 250 ml and 500 ml plastic bottles, 250 ml and 500 ml plastic bags, 1000 ml, 2000 ml and 3000 ml large volume bags.